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Abstract
Submit Date: 17 July 2022
The purpose of this study is to discuss the clinical, radiological and histopathological
Accept Date: 11 August 2022
th
Available online: 30 Sept. 2022 features of a rare grade 2 variant of meningioma. Patients and methods: A retrospective

analysis of the data of 6 patients who underwent surgery for a histopathologically proven
Keywords

chodroid meningioma. Results: Six patients’ pathology reports showed chordoid
meningioma. On imaging, four lesions (67%) were isointense in T1 while the other two





Chordoid,

were hypointense. On T2 weighted images, four patients were hyperintense (67%) and

meningioma

displayed non-restricted diffusion pattern with elevated values on corresponding

apparent

apparent diffusion coefficient maps. Pathologically, chordoid elements varied vastly

diffusion

among cases, radiological characters corresponded to choroid elements in all cases.

coefficient

Conclusion: choirdoid meningioma, as a rare meningioma entity, should be suspected
pre-operatively in cases with high signal intensity in T2, homogenous enhancement and
increased apparent diffusion coefficient, gross total surgical excision is curative.
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Earlier publications linked CM to systemic

Introduction
Meningioma is the second most common

manifestations, Castleman like syndrome, due to

primary intracranial tumor with an incidence of

reports

about 15 % of all intracranial neoplasms, the

hypochromic anemia in patients with CM 2, this

majority of meningiomas are benign with WHO

was explained by an assumed systemic reaction to

grade I. According to WHO classification,

peritumoral lymphoblastcellular infiltrate, this

chordoid meningioma (CM) as well as anaplastic

connection was ruled out later with case series

and atypical meningiomas are classified as grade

whose patients showed no such manifestations.

II.

describing

refractory

microcytic

The purpose of this study is to review and
Chordoid meningioma (CM) is a rare

subset,

representing

about

0.5%

of

all

analyze clinical, radiological, laboratory and
histopathological features of six cases of proven

meningiomas. These are graded as World Health

chordoid meningioma patients.

Organization (WHO) Grade II tumors and are

Patients and methods

1

associated with a high likelihood of recurrence .

Retrospective search in pathology archive

The subtype chordoid meningioma was first

using the term “chordoid meningioma” during the

2

reported by Kepes et al in 1988 in a case series of

period 2015 through 2020 was executed, patients’

seven patients with this pathology which was

medical reports were viewed for epidemiology,

characterized

clinical presentation, radiology, histopathology

by

“chordoma-like

histologic

appearance with a clustering of tumor cells against
a

myxoid

background”,

according to

and outcome.

their

Preoperative Magnetic Resonance Imaging

histopathological description. In 2007 WHO

(MRI) examinations were performed on 1.5 T MRI

classification, CM was first listed as grade II due

scanner (Inginia, Philips, Best, The Netherlands)

to reports of its aggressive behavior and high

equipped with a self-shielding gradient set.

tendency to rapid recurrence unless complete

Dedicated multi-channel head coil has been used

3

surgical resection is achieved .

for all cases. MRI protocol was as follow; axial

Histopathologically, CM is characterized

Fast Spin Echo (FSE) T1-weighted images, T2

by cords/nests composed of epithelioid or spindle

weighted

cells, in the background of pale, basophilic mucoid

recovery (FLAIR), and susceptibility weighted

matrix.

resemble

images (SWI), sagittal and coronal fast spin echo

physalliferous cells of chordoma, which are

T2 weighted images. Axial diffusion weighted

characterized by vacuolated cytoplasm. Pure CM

images (DWI) (b values of 0, 500 and 1000

cases are rare, however, the majority of CM

s/mm2) and apparent diffusion coefficient (ADC)

pathologies

typical

were then obtained before contrast administration.

meningioma tissues, the CM characters are higher

Contrast-enhanced T1-weighted imaging were

with recurrence. Chronic inflammatory infiltrates

obtained after administration of an intravenous

are often patchy when present, but may be

gadolinium-based contrast agent (0.1 mmol/kg).

Tumorous

are

cells

greatly

intermingled

4

prominent .

https://mmj.mans.edu.eg/home/vol51/iss3/4
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by

image,

fluid

attenuation

inversion

Images were analyzed for tumor location, size,
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signal characteristics on T1, T2 and FLAIR

high cellularity, increased nuclear/cytoplasmic

images, enhancement, diffusion pattern, perifocal

ratios in small cell, prominent nucleoli, sheet-like

edema, calcification, cystic areas, nearby osseous

growth, and foci necrosis with spontaneous or

changes and dural sinus involvement. Signal

geographic patterns. Malignancy was defined in

characteristics were classified as hypointense,

this study as the presence of obviously malignant

isointense, or hyperintense as compared to normal

cytology or an exceptionally high mitotic index

gray matter. Enhancement was classified as

(>20/10 HPF).

homogeneous or inhomogeneous while diffusion

Results

pattern was classified into restricted and free

Six patients’ pathology reports showed

patterns. The lesions had restricted diffusion when

chordoid meningioma, 3 of them were males,

it showed bright signal on diffusion weighted

mean age of 50.5 years which ranged from 35 to

images and corresponding low values on ADC

66. One patient was presented with scalp swelling,

maps. SWI was used to assess calcification within

one patient with seizures and all other patients (4

the tumor.

cases, 67%) were presented primarily with

Surgical specimens were fixed in 10%
neutral buffered formalin, routinely processed and

headache, two patients showed hemiparesis on
neurological examination.

paraffin embedded. Sections of 4 μm-thick were

On imaging, four lesions (67%) were

prepared for routine hematoxylin-eosin-stained

isointense in T1 while the other two were

(H&E) sections and immunohistochemistry.

hypointense. On T2 weighted images, four patients

Immunohistochemical

stains

were

were hyperintense (67%) and displayed non-

performed using Primary antibodies against Ki-67

restricted diffusion pattern with elevated values on

(rabbit PAb, clone MIB-1, 1:20 dilution, Neo

corresponding ADC maps. All lesions showed

Markers, USA), and epithelial membrane antigen

homogenous

(EMA) (clone GP1.4, 1:400 dilution, Novo-castra)

radiological criteria are summarized in Table 1,

were used. The Envision flex /HRP labeled

three patients (50%) showed calcification and one

polymer was applied using diaminobenzidin and

patient showed aggressive involving adjacent

hematoxylin for counterstaining on Autostainer

clavaria. Dimensions of the lesions ranged from

Link 48 system from DAKO.

2.8 cm in the smallest tumor to 6 cm in the biggest

enhancement.

Clinical

and

Mitotic index, as well as MIB-1 anti-gen

one with mean volume of 67.7 cc which ranged

immunohistochemical staining, were used to

from 16.5 cc to the biggest 60 cc. All lesions were

assess cell proliferation. The MIB-1 labeling index

supratentorial, most common site was frontal

(MI) was calculated in regions of maximal activity

convexity in 2 patients, one occipital, two parieto-

and expressed as percent nuclear area of staining.

occipital and one falcine. One patient showed

Diagnostic criteria, according to 2016 WHO

double lesion, small posterior fossa meningioma in

classification of CNS tumors, included either:

addition to the supratentorial one. Perifocal edema

mitotic index more than 4/10 high-power fields

and subsequently midline shift was seen in four

(HPF) or the presence of three of the next findings:

patients, in one patient the tumor invaded the

Published by Mansoura Medical Journal, 2023
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superior sagittal sinus with full obliteration and

appearance,

collateral circulation.

morphology was more than 90% of the examined

Preoperative

laboratory

areas;

investigations

for

otherwise,

these
they

two

cases,

were

chordoid

alternating

or

were within normal ranges for all patients, mean

intermixed with other subtypes; one transitional

hemoglobin concentration was 12.4 with range

and five meningothelial. Via thorough examination

from 11.3 to 14.3. The histological criteria and

of

percentage

are

differentiation were identified and proven by

summarized in Table 2. The patterns of chordoid

whorl formation or intranuclear inclusions. Based

morphology

1.

on solo pathological examination, five tumors

were

(83.3%) were classified as benign (grade I) and

epithelioid cells in 50% of cases (3/6), while

one tumor (16.7%) was classified as atypical

plump to spindle cells represented 50% (3/6), both

(grade II), if based solely on histologic grading

categories were arranged in nests, chords or

irrespective to chordoid parts. One recurrent tumor

cribriforms in mucoid matrix.

was classified as grade I. Lymphoplasmacytic

of

chordoid

are

Microscopically,

morphology

illustrated
the

in

tumorous

Figure
cells

the

specimens,

typical

meningothelial

infiltrate was present in three tumors (50%).

The chordoid elements constituted 20–
95% of the tumorous volumes, with 3 of 6 (50%)
over 70. Two specimens were characterized by
sweeping

and/or

uninterrupted

sheeting

Table 1 : Pathological features
MRI findings
Age

Sex

site

Case 1

66

f

Case 2

56

Case 3

T1

T2

Enhancement

DWI

Lt Sphenoid ridge

iso

hyper

Homogenous

m

Lt Occipitoparietal

Iso

Mixed

Homogenous

Non
Partial
restricted

38

f

Rt Frontal

Iso

Iso to
hypo

Homogenous

Case 4

58

m

Rt falcine - middle
3rd

Hypo

Hyper

Case 5

45

m

Lt frontal

Iso

Case 6

40

f

Rt occipital

Iso

Table 2: Clinical and radiological features
Case 1
Case 2
Increased cellularity
No
No
Small cell with high N/C ratio
No
No
Prominent nucleoli
Yes
No
Sheet-like growth
Yes
No
Geographic necrosis
Present
No
Malignant cytology
Absent
Absent
Mitotic index (10 HPF)
3
0
MIB-1 labeling index (%)
25
1
Lymphocyte infiltration
Present
Absent
Additional morphology
meningothelial meningothelial
Percentage
of
chordoid
95
20
morphology
Bone invasion
Absent
Absent

https://mmj.mans.edu.eg/home/vol51/iss3/4
DOI: 10.21608/mjmu.2022.150095.1128

Iso to
hypo
Hyper

Midline
shift
yes

Follow up
(months)
36

yes

14

Restricted

no

48

Homogenous

Non

no

34

Homogenous

Restricted

yes

44

Homogenous

Non

yes

12

Case 3
No
No
Yes
No
No
Absent
3
10
Present
Transitional
40

Case 4
No
No
Yes
Yes
No
Absent
0
15
Absent
meningothelial
90

Case 5
No
No
No
No
No
Absent
2
1
Present
meningothelial
30

Case 6
No
No
No
No
No
Absent
0
2
Absent
meningothelial
85

Present

Present

Absent

Absent

4
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Fifty six years old male patient, presented

Illustrative cases

to neurosurgical clinic with history of seizures

Case 1
Sixty six years old female patient,

which were controlled on medical anti-epileptic

presented to neurosurgery clinic with history of

therapy.

long standing headache and recent right side

bilateral visual affection with visual acuity of 3/60

hemiparesis, MRI brain with contrast examination

and 6/60. MRI brain showed (Fig 3) left parieto-

(Fig 1, A-C) coronal T2, T1 and post contrast T1

occipital meningioma. (A & B) axial T2WI and

images demonstrate high T2 and intermediate T1

FLAIR images show extra-axial SOL with mixed

signal intensity of a sphenoid ridge meningioma

low and high signal intensity. (C & D) axial DWI

with avid homogenous enhancement after contrast

and ADC images show partial restriction pattern of

administration. The lesion showed perifocal edema

the lesion corresponds to the T2 low signal

extending to adjacent motor area to which the

intensity and non-chordoid component. (E & F)

hemiparesis could be attributed. Laboratory results

pre and post contrast T1 images show avid

were within normal values. Total microscopic

enhancement of the lesion.

excision was performed, follow up period lasted
(Fig

for 12 months with no recurrence.

Neurological

examination

showed

Histopathological

examination

showed

4)

predominant

classic

showed

a

Histopathological examination (Fig 2)

meningothelial meningioma (WHO grade I) of

showed epithelioid cells, to plump cells, forming

average cellulariy with interspersed cords of

cords, cribriforms or nests, in a mucoid matrix

physaliferous like tumor cells with frequent

intermingled

meningothelial

intracytoplasmic vacuolization characteristic of

component evidenced by whorl formation or

chordoid meningioma (WHO grade II). The

intranuclear inclusions. The chordoid elements

chordoid component represents about 20% of

constituted

tumor. No detected Lymphoplasmacytic infiltrate

with

95%

Lymphoplasmacytic

classic

of

the

tumor

infiltrate

as

areas.

well

as

Geographic necrosis were present. No associated

nor Geographic necrosis. No evidence of brain
tissue invasion. MIB-1 labeling index was 1%.

brain tissue after through sampling. MIB-1
labeling index was 25%
Case 2

Figure 1: Case 1. A, Low-power view shows chordoid meningioma merging with areas of typical meningioma,
(H&E,x40). B, a photomicrograph showing the cord-like arrangement of the tumor cells within the myxoid stroma;
(H&E,x400).C, Lymphoplasmacytic cell infiltrate together with areas of necrosis D were also present (C & D,
H&E,x40).

Published by Mansoura Medical Journal, 2023
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Figure 2: Case 1.Sphenoid ridge meningioma; (A-C) coronal T2, T1 and post contrast T1 images demonstrate high T2
and low signal intensity of the meningioma with avid homogenous enhancement after contrast administration.

Figure 3: Case 2. A, Low-power view illustrates typical meningothelial meningioma (WHO grade I) with interspersed
cords of physaliferous like tumor cells with frequent intracytoplasmic vacuolization characteristic of chordoid
meningioma (WHO grade II) and absent lymphocytic infiltrate (H&E,x40). B, high power showing the cord-like
arrangement of the tumor cells (H&E,x400).

https://mmj.mans.edu.eg/home/vol51/iss3/4
DOI: 10.21608/mjmu.2022.150095.1128
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Figure 4: Case 2. Left parietal meningioma. (A & B) axial T2WI and FLAIR images show extra-axial SOL with mixed
low and high signal intensity. (C & D) axial DWI and ADC images show partial restriction pattern of the lesion
corresponds to the T2 low signal intensity and non-chordoid component. (E & F) pre and post contrast T1 images show
avid enhancement of the lesion.

are

Discussion
Chordoid meningioma is a rare variant of

associated

with

increased

hyperintensity in T2 weighted

preoperative
10

imaging

,

11

meningioma, though CM was first described by

specifically for chordoid meningioma Pond et al

Kepes in 1988, two earlier reports used the terms

proved increased apparent diffusion coefficient in

“vacuolated” and “myxomatous” to describe a

a series of chordoid meningioma patients. In our

special type of meningioma in 19775 and 19796 as

study, increased chordoid content percentage is

7

well as Connors et al case report in 1980 which

associated with hyperintense signal in T2 weighted

was the initiator to Kepes’ concerns. So far, only

images, while lesions with fewer chordoid element

around 150 cases of CM have been published in

showed isointensity. These specific radiological

English language literature.

findings can be attributed to the unique tumoral

All our patients were adults with mean age

architecture and histopathological characteristics

of 45.3 years old, with no gender preference, in

of the chordoid subtype. Diffusivity of water

contrary to Kepes’ original article which included

detected in MRI depends on extracellular matrix,

7 patients, all of them were below 20 years.

cell density and cytoplasm/nucleus ratio

Similar to our results, Linn’s series also included

Hyperintensity of CM on T2 weighted MRI noted

4

12 patients of adult population while Couce

8

12

,

13

.

and

and elevated ADC are hypothetically explained by

Epari 9 showed 95% and 75% adults respectively,

characteristic histopathological features of CM

which could be attributed to their bigger number of

which allows free water motion; the mucoid

cases.

extracellular
Laboratory tests of our patients showed no

cytoplasm/nucleus

matrix

and

ratio

due

increased
to

vacuolized

iron deficiency anemia, as well as Couce , Epari ,

cytoplasm. This gives a clinical importance to pre-

Linn and numerous case reports , which confirms

operative

that systemic manifestations of CM as Castleman

suspected, total excision including meningeal

syndrome is limited to pediatric group.

coverings should be the aim.

radiological

assessment,

as

when

Numerous studies correlated consistency

One patient (16.8 %) showed recurrence

of meningioma to preoperative MRI, softer lesions

within 2 years after total resection in our series,

Published by Mansoura Medical Journal, 2023
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while none of the other patients showed recurrence

Metastatic

lesions

can

mimic

CM

after microscopic total excision, although Couce et

particularly renal cell carcinoma and mucinous

al reported 61% recurrence rate in 10 years after

carcinomas of the gastrointestinal tract. However,

subtotal excision, this ratio is still higher than

clinical and radiological correlation along with

recurrence rate for grade I meningioma after the

immunohistochemical panel for the primary tumor

same procedure, the follow up period for our study

are often adequate for the correct diagnosis.

is not sufficient to judge recurrence.

Recent studies have shown that D2‑40, a

According to 2016 newest CNS tumors

monoclonal antibody initially developed against

classification, CM is classified as grade II

podoplanin is a selective marker of lymphatic

meningioma, due to a high rate of recurrence,

endothelium and aids in identification of various

particularly

resection.

benign and malignant tissues. Immunoreactivity

consists of cords or

with D2‑40 antibody in CM is useful in the

trabeculae of round to flattened cells with

differentiation from both extraskeletal myxoid

eosinophilic or vacuolated cytoplasm and an

chondrosarcoma and chordoma 14.

following

Morphologically, CM

abundant

mucoid

subtotal

matrix

background.

Such

Although some authors

17

have implicated

chordoid areas are often interspersed with more

the mucin rich, chordoid morphology for rapid

typical meningothelial or transitional areas. The

enlargement and aggressiveness of CM, it has not

pure chordoid morphology is uncommon but can

been established as an independent prognostic

lead to a diagnostic dilemma when present

feature. The most important prognostic factor in

exclusively. The differential diagnosis in this

patients with meningiomas is the extent of

scenario includes tumors within or near the CNS

resection. The recurrence rate after subtotal

exhibiting chondroid/myxoid appearance. These

resection of CM is high 1. However, complete

are

myxoid

resection may not be possible in large tumors,

extra-skeletal),

which are present near important functional areas

myxopapillary

of the brain or major blood vessels. Postoperative

chordoma,

chondrosarcoma
low‑grade

chordoid
(skeletal

glioma,
and

chondrosarcoma,

ependymoma,

and

mucinous

metastatic

carcinomas 14,15.

radiotherapy is recommended in such cases 18.
Conclusion

A panel of immunohistochemical stains is

Chordoid meningioma is a rare variant

required for accurate diagnosis. Chordoma is very

which

important because of its striking histological

radiologically

resemblance to CM. EMA positivity in CM cannot

anticipation of such and aggressive pathology is

alone differentiate it from chordoma as the latter is

important to plan radical excision.

can’t

be

clinically
suspected.

identified,

but

Pre-operative

typically EMA/CK/S‑100 positive. Strong GFAP
reactivity is present in chordoid gliomas and

Funding:

Myxopapillary ependymomas which are also

No fund was received to perform this research.

positive for S‑100 as well as Chondrosarcomas 16.
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